- Joined
- Jul 25, 2008
- Messages
- 1,700
I thought it might be nice to hear from someone else besides Dat.
From: Amino Acids and Proteins for the Athlete:The Anabolic Edge, Mauro G. Di Pasquale, CRC Press 2008
Problems with Exogenous Growth Hormone
Increasing our own natural endogenous levels of GH is an effective way to get the benefits of increased GH levels and for reasons outlined below may be a natural alternative to the use of exogenous GH.
The use of recombinant or synthetic GH (the only kind available since 1985 when the possibility of prion infection resulting in Creutzfeldt–Jakob disease, a variant of mad cow disease, halted the use of GH harvested from the pituitaries of cadavers) only provides limited GH exposure.
That is because human GH represents a family of proteins rather than a single hormone. In fact, the circulation contains over 100 GH forms, and because we have yet to discover enough about the various forms, the net biological activity of this mixture is difficult to predict since the exogenous recombinant GH represents only 20% or so of the mix.
Thus far, most of the research has been largely confined to monomeric 22-kDa, the same GH that is available for exogenous use. However, while it is certainly effective for the original intended purpose, namely growth promotion, it is not known if this is sufficient for optimal growth. It is unlikely that it can fulfill all the functions of the GH family that are naturally present in the body. Moreover, the use of one GH variant likely decreases the production of the other variants in the body thus limiting the normal biological activity of GH.
On the contrary, the use of exogenous GH shuts down our own GH production and may produce some dysfunction in the endogenous production of GH once the therapy is stopped. This may simulate the situation of hypogonadotropic hypogonadism that sometimes occurs secondary to the use of anabolic steroids.
Since it takes a variable amount of time for our body to ramp up the GH machinery once GH therapy is discontinued, for a certain period of time, a GH deficiency (GHD) may exist. In some cases it may be possible that some dysfunction might exist as a result of which the production of GH is below that which was produced before the GH therapy.
From: Amino Acids and Proteins for the Athlete:The Anabolic Edge, Mauro G. Di Pasquale, CRC Press 2008
Problems with Exogenous Growth Hormone
Increasing our own natural endogenous levels of GH is an effective way to get the benefits of increased GH levels and for reasons outlined below may be a natural alternative to the use of exogenous GH.
The use of recombinant or synthetic GH (the only kind available since 1985 when the possibility of prion infection resulting in Creutzfeldt–Jakob disease, a variant of mad cow disease, halted the use of GH harvested from the pituitaries of cadavers) only provides limited GH exposure.
That is because human GH represents a family of proteins rather than a single hormone. In fact, the circulation contains over 100 GH forms, and because we have yet to discover enough about the various forms, the net biological activity of this mixture is difficult to predict since the exogenous recombinant GH represents only 20% or so of the mix.
Thus far, most of the research has been largely confined to monomeric 22-kDa, the same GH that is available for exogenous use. However, while it is certainly effective for the original intended purpose, namely growth promotion, it is not known if this is sufficient for optimal growth. It is unlikely that it can fulfill all the functions of the GH family that are naturally present in the body. Moreover, the use of one GH variant likely decreases the production of the other variants in the body thus limiting the normal biological activity of GH.
On the contrary, the use of exogenous GH shuts down our own GH production and may produce some dysfunction in the endogenous production of GH once the therapy is stopped. This may simulate the situation of hypogonadotropic hypogonadism that sometimes occurs secondary to the use of anabolic steroids.
Since it takes a variable amount of time for our body to ramp up the GH machinery once GH therapy is discontinued, for a certain period of time, a GH deficiency (GHD) may exist. In some cases it may be possible that some dysfunction might exist as a result of which the production of GH is below that which was produced before the GH therapy.